Alnylam Pharmaceuticals
ALNY
#645
Rank
โ‚ฌ30.13 B
Marketcap
233,65ย โ‚ฌ
Share price
-0.77%
Change (1 day)
57.03%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company